Subchronic hydrocortisone treatment alters auditory evoked potentials in normal subjects. 2000

C H Ashton, and B Lunn, and V R Marsh, and A H Young
Department of Psychiatry, School of Neuroscience and Psychiatry, University of Newcastle, Royal Victoria Infirmary, Newcastle upon Tyne, UK.

BACKGROUND Abnormalities of cortical evoked potentials and background electroencephalographic (EEG) frequencies occur in several psychiatric disorders, some of which, especially depression, are associated with hypercortisolaemia. However, there have been few investigations of the effects of exogenously administered cortisol on waking EEG measures. OBJECTIVE To examine the effects of subchronic hydrocortisone administration on auditory evoked potentials and background EEG activity. METHODS Hydrocortisone, 20 mg twice daily, or placebo was administered to 30 normal male volunteers for 7 days in a between-subjects, double-blind trial. Auditory evoked potentials and EEG frequencies were measured on the last day. RESULTS Hydrocortisone significantly increased the amplitudes of the N1P2 and P300 components of the auditory evoked response, but there was no change in background EEG. CONCLUSIONS The results indicate that subchronic hydrocortisone treatment in normal subjects increases the amplitude of auditory evoked potentials, possibly reflecting a central alerting effect.

UI MeSH Term Description Entries
D008297 Male Males
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D005072 Evoked Potentials, Auditory The electric response evoked in the CEREBRAL CORTEX by ACOUSTIC STIMULATION or stimulation of the AUDITORY PATHWAYS. Auditory Evoked Potentials,Auditory Evoked Response,Auditory Evoked Potential,Auditory Evoked Responses,Evoked Potential, Auditory,Evoked Response, Auditory,Evoked Responses, Auditory,Potentials, Auditory Evoked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D018913 Event-Related Potentials, P300 A late-appearing component of the event-related potential. P300 stands for a positive deflection in the event-related voltage potential at 300 millisecond poststimulus. Its amplitude increases with unpredictable, unlikely, or highly significant stimuli and thereby constitutes an index of mental activity. (From Campbell, Psychiatric Dictionary, 6th ed) Evoked Potentials, P300 Component,P3 Event Related Potential,P300 Event-Related Potential,P300 Event-Related Potentials,Event-Related Potentials, P3,P3 Event-Related Potentials,P300 Component,P3a Event-Related Potentials,P3b Event-Related Potentials,Event Related Potentials, P3,Event Related Potentials, P300,Event-Related Potential, P3,Event-Related Potential, P300,Event-Related Potential, P3a,Event-Related Potential, P3b,Event-Related Potentials, P3a,Event-Related Potentials, P3b,P3 Event Related Potentials,P3 Event-Related Potential,P300 Components,P300 Event Related Potential,P300 Event Related Potentials,P3a Event Related Potentials,P3a Event-Related Potential,P3b Event Related Potentials,P3b Event-Related Potential

Related Publications

C H Ashton, and B Lunn, and V R Marsh, and A H Young
December 1977, Nature,
C H Ashton, and B Lunn, and V R Marsh, and A H Young
February 1988, Minerva medica,
C H Ashton, and B Lunn, and V R Marsh, and A H Young
June 1997, The International journal of neuroscience,
C H Ashton, and B Lunn, and V R Marsh, and A H Young
January 1988, Scandinavian audiology. Supplementum,
C H Ashton, and B Lunn, and V R Marsh, and A H Young
January 1982, The Annals of otology, rhinology, and laryngology,
C H Ashton, and B Lunn, and V R Marsh, and A H Young
April 1978, Electroencephalography and clinical neurophysiology,
C H Ashton, and B Lunn, and V R Marsh, and A H Young
September 2006, Acta neurologica Taiwanica,
C H Ashton, and B Lunn, and V R Marsh, and A H Young
January 1971, Brain research,
C H Ashton, and B Lunn, and V R Marsh, and A H Young
March 1989, The Laryngoscope,
C H Ashton, and B Lunn, and V R Marsh, and A H Young
July 2020, International archives of otorhinolaryngology,
Copied contents to your clipboard!